{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.11.1111","meta":{"versionId":"22","lastUpdated":"2021-09-14T01:01:12.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-09-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.110.11.1111"}],"version":"20210914","name":"HepatitisBVaccineAdministered","title":"Hepatitis B Vaccine Administered","status":"active","experimental":false,"date":"2021-09-14T01:01:12-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for a Hepatitis B vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for a Hepatitis B vaccination.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"90697","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"},{"code":"90723","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"},{"code":"90740","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use"},{"code":"90744","display":"Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use"},{"code":"90747","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use"},{"code":"90748","display":"Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"}]}]},"expansion":{"identifier":"urn:uuid:d9a3a34a-2e20-4b7c-a771-103ba43387a2","timestamp":"2023-12-11T02:09:50-05:00","total":6,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90697","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90723","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90740","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90744","display":"Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90747","display":"Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90748","display":"Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"}]}}